Marcadores Tumorais em Gastrenterologia

Detalhes bibliográficos
Autor(a) principal: Lopes, Antônio Luiz Fernandes
Data de Publicação: 2023
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Brasileira de Cancerologia (Online)
Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/3140
Resumo: The author has made a review upon Gastroenterological Tumor Markers. He emphasizes their usefulness and relativity in the diagnosis and prognosis of some malignant neoplasms (specially: hepatocellular carcinoma, adenocarcinoma of pancreas and colon câncer) of the digestive tract. AIso, the value of these markers turns outstanding mainly among the known high-risk groups (cirrhotics and active chronic hepatitis carriers or chronic carriers of virus B, among others); in those groups, sometimes, the dosage of alphafetoprotein, v. gr., could be very important as for the hepatocellular carcinoma screening, for instance. Some markers recently developed from monoclonal antibodies, nowadays undertesting, are commented on as well.
id INCA-1_c0357703b2df90f8356c74b1605d228d
oai_identifier_str oai:rbc.inca.gov.br:article/3140
network_acronym_str INCA-1
network_name_str Revista Brasileira de Cancerologia (Online)
repository_id_str
spelling Marcadores Tumorais em GastrenterologiaMarcadores TumoraisCâncer do CólonHepatocarcinomaAdenocarcinoma do PâncreasPropedêutica OncologiaTumors markersMalignant Neoplasms of the Digestive TractThe author has made a review upon Gastroenterological Tumor Markers. He emphasizes their usefulness and relativity in the diagnosis and prognosis of some malignant neoplasms (specially: hepatocellular carcinoma, adenocarcinoma of pancreas and colon câncer) of the digestive tract. AIso, the value of these markers turns outstanding mainly among the known high-risk groups (cirrhotics and active chronic hepatitis carriers or chronic carriers of virus B, among others); in those groups, sometimes, the dosage of alphafetoprotein, v. gr., could be very important as for the hepatocellular carcinoma screening, for instance. Some markers recently developed from monoclonal antibodies, nowadays undertesting, are commented on as well.O autor procedeu a uma revisão sobre Marcadores Tumorais em Gastrenterologia. O relato enfatiza a utilidade e relatividade dessa metodologia quanto ao diagnóstico e prognóstico de alguns neoplasmas malignos (especialmente: carcinoma hepatocelular, adenocarcinoma de pâncreas e do cólon) do tracto digestivo. Outrossim, tais marcadores adquirem valor proeminente sobremaneira entre os grupos-de-risco conhecidos (entre os quais: cirróticos e portadores de hepatite crônica ativa ou do vírus B); nestes grupos, dentre outros métodos, eventualmente a dosagem de AFP, por exemplo, podería ser muito importante quanto ao rastreamento do CMC. Marcadores recém-desenvolvidos a partir de anticorpos monoclonais, atualmente em Investigação, são igualmente objeto de análise.INCA2023-07-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionRevisão de literaturaapplication/pdfhttps://rbc.inca.gov.br/index.php/revista/article/view/314010.32635/2176-9745.RBC.1989v35n3/4.3140Revista Brasileira de Cancerologia; Vol. 35 No. 3/4 (1989): Jul./Dec.; 27-34Revista Brasileira de Cancerologia; Vol. 35 Núm. 3/4 (1989): jul./dic.; 27-34Revista Brasileira de Cancerologia; v. 35 n. 3/4 (1989): jul./dez; 27-342176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporhttps://rbc.inca.gov.br/index.php/revista/article/view/3140/1999https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessLopes, Antônio Luiz Fernandes2023-07-31T18:06:02Zoai:rbc.inca.gov.br:article/3140Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2023-07-31T18:06:02Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false
dc.title.none.fl_str_mv Marcadores Tumorais em Gastrenterologia
title Marcadores Tumorais em Gastrenterologia
spellingShingle Marcadores Tumorais em Gastrenterologia
Lopes, Antônio Luiz Fernandes
Marcadores Tumorais
Câncer do Cólon
Hepatocarcinoma
Adenocarcinoma do Pâncreas
Propedêutica Oncologia
Tumors markers
Malignant Neoplasms of the Digestive Tract
title_short Marcadores Tumorais em Gastrenterologia
title_full Marcadores Tumorais em Gastrenterologia
title_fullStr Marcadores Tumorais em Gastrenterologia
title_full_unstemmed Marcadores Tumorais em Gastrenterologia
title_sort Marcadores Tumorais em Gastrenterologia
author Lopes, Antônio Luiz Fernandes
author_facet Lopes, Antônio Luiz Fernandes
author_role author
dc.contributor.author.fl_str_mv Lopes, Antônio Luiz Fernandes
dc.subject.por.fl_str_mv Marcadores Tumorais
Câncer do Cólon
Hepatocarcinoma
Adenocarcinoma do Pâncreas
Propedêutica Oncologia
Tumors markers
Malignant Neoplasms of the Digestive Tract
topic Marcadores Tumorais
Câncer do Cólon
Hepatocarcinoma
Adenocarcinoma do Pâncreas
Propedêutica Oncologia
Tumors markers
Malignant Neoplasms of the Digestive Tract
description The author has made a review upon Gastroenterological Tumor Markers. He emphasizes their usefulness and relativity in the diagnosis and prognosis of some malignant neoplasms (specially: hepatocellular carcinoma, adenocarcinoma of pancreas and colon câncer) of the digestive tract. AIso, the value of these markers turns outstanding mainly among the known high-risk groups (cirrhotics and active chronic hepatitis carriers or chronic carriers of virus B, among others); in those groups, sometimes, the dosage of alphafetoprotein, v. gr., could be very important as for the hepatocellular carcinoma screening, for instance. Some markers recently developed from monoclonal antibodies, nowadays undertesting, are commented on as well.
publishDate 2023
dc.date.none.fl_str_mv 2023-07-31
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Revisão de literatura
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/3140
10.32635/2176-9745.RBC.1989v35n3/4.3140
url https://rbc.inca.gov.br/index.php/revista/article/view/3140
identifier_str_mv 10.32635/2176-9745.RBC.1989v35n3/4.3140
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/3140/1999
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv INCA
publisher.none.fl_str_mv INCA
dc.source.none.fl_str_mv Revista Brasileira de Cancerologia; Vol. 35 No. 3/4 (1989): Jul./Dec.; 27-34
Revista Brasileira de Cancerologia; Vol. 35 Núm. 3/4 (1989): jul./dic.; 27-34
Revista Brasileira de Cancerologia; v. 35 n. 3/4 (1989): jul./dez; 27-34
2176-9745
reponame:Revista Brasileira de Cancerologia (Online)
instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
instname_str Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron_str INCA
institution INCA
reponame_str Revista Brasileira de Cancerologia (Online)
collection Revista Brasileira de Cancerologia (Online)
repository.name.fl_str_mv Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
repository.mail.fl_str_mv rbc@inca.gov.br
_version_ 1797042234299777024

Registros relacionados